CORC

浏览/检索结果: 共12条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report 期刊论文
BMC GASTROENTEROLOGY, 2019, 卷号: 19, 期号: 1
作者:  Dong, Zhao-Ru;  Xia, Yan-Ni;  Zhao, Rui-Yi;  Wu, Rui;  Liu, Kai-Xuan
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/11
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70, 期号: 5, 页码: 893-903
作者:  Wang, Qiuhe;  Xia, Dongdong;  Bai, Wei;  Wang, Enxin;  Sun, Junhui
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/11
Optimal time-point of response assessment was associated with tumour burden in patients with unresectable hepatocellular carcinoma undergoing repeated transarterial chemoembolization 会议论文
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), APR 10-14, 2019
作者:  Xia, Dongdong;  Wang, Enxin;  Wang, Qiuhe;  Bai, Wei;  Wang, Zhexuan
收藏  |  浏览/下载:15/0  |  提交时间:2019/12/31
Efficacy and safety of raltitrexed-based transarterial chemoembolization for colorectal cancer liver metastases 期刊论文
ANTI-CANCER DRUGS, 2018, 卷号: 29, 期号: 10, 页码: 1021-1025
作者:  Shao, Guoliang;  Liu, Ruibao;  Ding, Wenbin;  Lu, Ligong;  Li, Wentao
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/11
Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients 期刊论文
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 卷号: 14, 期号: 1, 页码: 196-200
作者:  Zhang, Kai;  Sun, Xiangyang;  Xie, Fubo;  Jian, Wencheng;  Li, Caixia
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/11
Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma 期刊论文
BMC GASTROENTEROLOGY, 2018, 卷号: 18, 期号: 1
作者:  Wu, Huiyong;  Zhao, Wei;  Zhang, Jianbo;  Han, Jianjun;  Liu, Shuguang
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/11
Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors 期刊论文
MEDICINE, 2017, 卷号: 96, 期号: 33
作者:  Gao, Zhendong;  Du, Gang;  Pang, Yuguang;  Fu, Zhihao;  Liu, Chongzhong
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/16
Evidence-based two-and-seven criteria according to tumor number and size best help to predict survival of patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization 会议论文
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, APR 19-23, 2017
作者:  Xia, D.;  Bai, W.;  Huang, M.;  Sun, J.;  Wang, E.
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/31
Comparison of overall survival in patients with unresectable hepatic metastases with or without transarterial chemoembolization: A Propensity Score Matching Study 期刊论文
SCIENTIFIC REPORTS, 2016, 卷号: 6
作者:  Wang, F. Y.;  Meng, W.;  Li, Y.;  Li, T.;  Qin, C. Y.
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/16
Fluctuation and significance of circulating endothelial cells during the therapeutic process of transarterial chemoembolization of hepatocellular carcinoma 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 卷号: 9, 期号: 2, 页码: 3041-3047
作者:  Zhang, Kai;  Wu, Jiahong;  Wei, Shufang;  Yang, Yongmei;  Yang, Fangfang
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/16


©版权所有 ©2017 CSpace - Powered by CSpace